Tau and Parkinson disease

被引：24
|
作者：
Spillantini, MG
Goedert, M
机构：
[1] Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England
[2] Univ Cambridge, Dept Neurol, Cambridge CB2 2PY, England
[3] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 286卷 / 18期
关键词：
D O I：
10.1001/jama.286.18.2324
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2324 / 2326
页数：3
相关论文
共 50 条
  • [41] Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
    Zhang, Jing
    Mattison, Hayley A.
    Liu, Changqin
    Ginghina, Carmen
    Auinger, Peggy
    McDermott, Michael P.
    Stewart, Tessandra
    Kang, Un Jung
    Cain, Kevin C.
    Shi, Min
    ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 671 - 682
  • [42] Tau pathology is associated to cognitive and not motor function in Parkinson's disease
    Liepelt-Scarfone, I.
    Vanderstichele, H.
    Maetzler, W.
    Francois, C.
    Schulte, C.
    Timmers, M.
    Van Nueten, L.
    Salvadore, G.
    Brockmann, K.
    Gasser, T.
    Streffer, J.
    Stoops, E.
    Berg, D.
    MOVEMENT DISORDERS, 2019, 34 : S696 - S697
  • [43] Role of tau oligomers in Parkinson's disease and dementia with Lewy bodies
    Lasagna-Reeves, C. A.
    Roi, B.
    Bakhoum, M.
    Guerrero-Munoz, M. I.
    Castillo-Caranza, D. L.
    Kayed, R.
    Jackson, G. R.
    Troncoso, J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S207 - S207
  • [44] Correlation of tau gene polymorphism with age at onset of Parkinson's disease
    Kobayashi, Hideaki
    Ujike, Hiroshi
    Hasegawa, Junko
    Yamamoto, Mitsutoshi
    Kanzaki, Akihiro
    Sora, Ichiro
    NEUROSCIENCE LETTERS, 2006, 405 (03) : 202 - 206
  • [45] Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease
    Ezquerra, Mario
    Campdelacreu, Jaume
    Gaig, Carles
    Compta, Yaroslau
    Munoz, Esteban
    Marti, Maria Jose
    Valldeoriola, Francesc
    Tolosa, Eduardo
    NEUROSCIENCE LETTERS, 2008, 448 (01) : 20 - 23
  • [46] Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease
    Henderson, Michael X.
    Sengupta, Medha
    Trojanowski, John Q.
    Lee, Virginia M. Y.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [47] The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease
    de Silva, R
    Hardy, J
    Crook, J
    Khan, N
    Graham, EA
    Morris, CM
    Wood, NW
    Lees, AJ
    NEUROSCIENCE LETTERS, 2002, 330 (02) : 201 - 203
  • [48] Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
    Parnetti, Lucilla
    Chiasserini, Davide
    Bellomo, Gianni
    Giannandrea, David
    De Carlo, Claudia
    Qureshi, Mohamed M.
    Ardah, Mustafa T.
    Varghese, Shiji
    Bonanni, Laura
    Borroni, Barbara
    Tambasco, Nicola
    Eusebi, Paolo
    Rossi, Aroldo
    Onofrj, Marco
    Padovani, Alessandro
    Calabresi, Paolo
    El-Agnaf, Omar
    MOVEMENT DISORDERS, 2011, 26 (08) : 1428 - 1435
  • [49] Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
    David J. Irwin
    Virginia M.-Y. Lee
    John Q. Trojanowski
    Nature Reviews Neuroscience, 2013, 14 : 626 - 636
  • [50] Tau/α-Synuclein Ratio and Inflammatory Proteins in Parkinson's Disease: An Exploratory Study
    Delgado-Alvarado, Manuel
    Gago, Belen
    Gorostidi, Ana
    Jimenez-Urbieta, Haritz
    Dacosta-Aguayo, Rosalia
    Navalpotro-Gomez, Irene
    Ruiz-Martinez, Javier
    Bergareche, Alberto
    Marti-Masso, Jose F.
    Martinez-Lage, Pablo
    Izagirre, Andrea
    Rodriguez-Oroz, Maria C.
    MOVEMENT DISORDERS, 2017, 32 (07) : 1066 - 1073
12345